English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

of results A total of 146 HIV-1-infected patients with viral failure were evaluated. Patients were mainly male (75.3%), median age 42 years. Median time of ENF treatment was 13 weeks. Median baseline characteristics: VL 4.28 log10 cop/mL, CD4 cell count 191 cells/mL, four previous IPs and four previous RTIs. TPV/r and DRV/r was used by 40.4% and 35.6% of patients, respectively. Patients with CD4 count >100 cells/mL were 74% and patients viral load (VL) 100 cells/mL (p < 0.05).

Positive predictive factors in HIV-1 patients treated with enfuvirtide plus an OB that include an active boosted PI. Preliminary FastFuz study results